Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,098 products)
- Organic Building Blocks(61,034 products)
Found 199601 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
2-[Hydroxy(thiophen-2-yl)methyl]butanenitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H11NOSPurity:Min. 95%Molecular weight:181.26 g/mol4-Methyl-6-oxopiperidine-3-carboxylic acids
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H11NO3Purity:Min. 95%Molecular weight:157.2 g/mol5-Phenyl-isothiazolidine 1,1-dioxide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H11NO2SPurity:Min. 95%Molecular weight:197.26 g/mol4-[(4-Aminobutyl)amino]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C17H21ClN4O4Purity:Min. 95%Molecular weight:380.8 g/mol2-{3-Amino-8-[(tert-butoxy)carbonyl]-8-azabicyclo[3.2.1]octan-3-yl}acetic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H24N2O4Purity:Min. 95%Molecular weight:284.4 g/molAHR antagonist 1
CAS:<p>AHR antagonist 1 is a molecule that inhibits the activation of the AHR pathway. It has been shown to inhibit tumor growth in mouse models of cancer. The molecular mechanism of action is not well understood, but it may be due to inhibition of tryptophan metabolism and suppression of kynurenine production. This agent has also been shown to have anti-inflammatory effects through inhibition of the production of IL-1β and TNF-α in macrophages. There are also indications that AHR antagonist 1 may be effective against other types of cancers because it targets a variety of intracellular targets.</p>Formula:C20H17ClFN3O3Purity:Min. 95%Molecular weight:401.82 g/mol3-Amino-4,4,4-trifluorobutan-2-ol hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C4H9ClF3NOPurity:Min. 95%Molecular weight:179.57 g/mol2-(1-methylethyl)pyrimidine-5-carbaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H10N2OPurity:Min. 95%Molecular weight:150.18 g/mol2-Ethoxypyrimidine-5-carbaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H8N2O2Purity:Min. 95%Molecular weight:152.15 g/mol2-Chloro-5-[(4-chlorophenyl)sulfamoyl]benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H9Cl2NO4SPurity:Min. 95%Molecular weight:346.2 g/mol3-{[(4-Methylphenyl)methyl]sulfanyl}-1H-1,2,4-triazol-5-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H12N4SPurity:Min. 95%Molecular weight:220.3 g/mol1-(4-Methylbenzenesulfonyl)piperidine-3-carbohydrazide
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H19N3O3SPurity:Min. 95%Molecular weight:297.38 g/molMethyl 2-amino-5-(trifluoromethoxy)benzoate
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H8F3NO3Purity:Min. 95%Molecular weight:235.16 g/mol4-Chloro-6-(trifluoromethoxy)quinazoline
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H4ClF3N2OPurity:Min. 95%Molecular weight:248.59 g/mol(3-Methanesulfonylphenyl)hydrazine
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H10N2O2SPurity:Min. 95%Molecular weight:186.23 g/molMethyl 5-[(4-chloro-1H-pyrazol-1-yl)methyl]-2-furoate
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H9ClN2O3Purity:Min. 95%Molecular weight:240.64 g/molMethyl 4-[(4-bromo-1H-pyrazol-1-yl)methyl]benzoate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H11BrN2O2Purity:Min. 95%Molecular weight:295.13 g/mol5-Methoxy-2-(1H-pyrazol-5-yl)phenol
CAS:<p>5-Methoxy-2-(1H-pyrazol-5-yl)phenol is a plant extract that has been shown to reduce inflammation and suppress the growth of cancer cells. It has also been found to confer protection from capillary damage in rats by inhibiting the expression of inflammatory cells and cytokines. 5-Methoxy-2-(1H-pyrazol-5-yl)phenol belongs to a family of compounds that possess structural modifications, such as an NMR study which revealed that it has a unique molecular structure. The effects of this compound on pluripotent stem cells have also been studied, with promising results. This compound may be useful in treating diseases such as atherosclerosis, hypertension, and diabetes.</p>Formula:C10H10N2O2Purity:Min. 95%Molecular weight:190.2 g/mol3-[(4-Bromo-3-nitro-1H-pyrazol-1-yl)methyl]benzoic acid
CAS:Versatile small molecule scaffoldFormula:C11H8BrN3O4Purity:Min. 95%Molecular weight:326.1 g/molN-{[4-(Morpholin-4-yl)-3-nitrophenyl]methylidene}hydroxylamine
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H13N3O4Purity:Min. 95%Molecular weight:251.24 g/mol1,3-Dioxo-2-(tetrahydro-furan-2-ylmethyl)-2,3-dihydro-1H-isoindole-5-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H13NO5Purity:Min. 95%Molecular weight:275.26 g/mol2-{[2-Oxo-2-(piperidin-1-yl)ethyl]sulfanyl}-3-phenyl-3,4-dihydroquinazolin-4-one
CAS:Versatile small molecule scaffoldFormula:C21H21N3O2SPurity:Min. 95%Molecular weight:379.5 g/mol2-{[5-(4-tert-Butylphenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C20H21N3O2SPurity:Min. 95%Molecular weight:367.5 g/mol4-(3,5-Dimethyl-pyrazol-1-ylmethyl)-benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H14N2O2Purity:Min. 95%Molecular weight:230.26 g/mol2-(2-Bromoethyl)-1,3-dithiolane
CAS:<p>Versatile small molecule scaffold</p>Formula:C5H9BrS2Purity:Min. 95%Molecular weight:213.2 g/mol7-Bromo-5-chloroindoline-2,3-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H3NO2ClBrPurity:Min. 95%Molecular weight:260.47 g/mol1-(5-Nitro-1H-indol-3-yl)propan-1-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H10N2O3Purity:Min. 95%Molecular weight:218.21 g/mol3,4-dihydro-1h-spiro[naphthalene-2,4'-piperidin]-1-one hcl
CAS:Versatile small molecule scaffoldFormula:C14H18ClNOPurity:Min. 95%Molecular weight:251.75 g/mol4-[(4-Chloro-3-nitro-1H-pyrazol-1-yl)methyl]benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H8ClN3O4Purity:Min. 95%Molecular weight:281.65 g/mol5-Methyl-2,3-dihydro-1-benzofuran-2-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H10O3Purity:Min. 95%Molecular weight:178.18 g/molN-[2-Oxo-6-(trifluoromethyl)-2H-pyran-3-yl]benzamide
CAS:<p>N-[2-Oxo-6-(trifluoromethyl)-2H-pyran-3-yl]benzamide is a white crystalline solid that is soluble in water and ethanol. It can be produced by the reaction of hydroxylamine, sodium hydroxide, and 6-(trifluoromethyl)-2H-pyran-3-one. The product of this reaction is an oxime that can be converted to N-[2-oxo-6-(trifluoromethyl)-2H-pyran-3-yl]benzamide by acidification with hydrochloric acid. When N-[2-oxo-6-(trifluoromethyl)-2H-pyran-3 -yl]benzamide is reacted with hydroxide or hydrazine, it undergoes substitution at the 2 position. This reaction produces a substituted benzamide as the</p>Formula:C13H8F3NO3Purity:Min. 95%Molecular weight:283.2 g/mol3-Amino-6-(2-methylpropyl)thieno[2,3-b]pyridine-2-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C12H14N2O2SPurity:Min. 95%Molecular weight:250.3 g/molMethyl 2-{[4-(4-methylphenyl)-3-oxo-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-5-yl]sulfanyl}acetate
CAS:<p>Versatile small molecule scaffold</p>Formula:C20H20N2O3S2Purity:Min. 95%Molecular weight:400.5 g/mol4-(Propan-2-yl)piperidine hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H18ClNPurity:Min. 95%Molecular weight:163.69 g/molEthyl 3-amino-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H15NO2SPurity:Min. 95%Molecular weight:225.31 g/moltert-Butyl N-(but-3-en-1-yl)-N-methylcarbamate
CAS:Versatile small molecule scaffoldFormula:C10H19NO2Purity:Min. 95%Molecular weight:185.26 g/molrac-(1R,2R,6S,7S)-4-Azatricyclo[5.2.2.0,2,6]undec-8-ene hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H16ClNPurity:Min. 95%Molecular weight:185.7 g/mol1-(1,3-Diphenyl-1H-pyrazole-4-carbothioyl)piperidine
CAS:<p>Versatile small molecule scaffold</p>Formula:C21H21N3SPurity:Min. 95%Molecular weight:347.5 g/molN-(3-Fluoro-4-methylphenyl)prop-2-enamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H10FNOPurity:Min. 95%Molecular weight:179.19 g/mol3-(5-Methyl-4H-1,2,4-triazol-3-yl)benzonitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H8N4Purity:Min. 95%Molecular weight:184.2 g/mol3-(Methylsulfanyl)pyridine-2-carbonitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H6N2SPurity:Min. 95%Molecular weight:150.2 g/mol(3-Fluoro-4-methylpyridin-2-yl)methanamine dihydrochloride
CAS:<p>3-Fluoro-4-methylpyridin-2-yl)methanamine dihydrochloride (FMPD) is a template for the synthesis of new pyridine inhibitors of thrombin. The orally bioavailable FMPD has demonstrated anti-thrombotic activity in animal models and is being investigated as a potential therapeutic agent for the treatment or prevention of thrombosis. FMPD inhibits thrombin by binding to its active site, preventing it from cleaving fibrinogen and thereby inhibiting clot formation. This activity is increased by the presence of heparin, which facilitates the release of endogenous thrombin inhibitors, such as hirudin and antithrombin III.</p>Formula:C7H11Cl2FN2Purity:Min. 95%Molecular weight:213.08 g/mol3-({3-Cyano-4H,5H,6H-cyclopenta[b]thiophen-2-yl}carbamoyl)propanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H12N2O3SPurity:Min. 95%Molecular weight:264.3 g/mol2-{[(Pyridin-3-ylmethyl)carbamoyl]methoxy}acetic acid
CAS:Versatile small molecule scaffoldFormula:C10H12N2O4Purity:Min. 95%Molecular weight:224.21 g/mol1-[4-(Trifluoromethyl)phenyl]piperazin-2-one hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H11F3N2OPurity:Min. 95%Molecular weight:244.21 g/mol4,5-Dimethyl-2-(2-methylpropanamido)thiophene-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H15NO3SPurity:Min. 95%Molecular weight:241.31 g/mol{[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]thio}acetic acid
CAS:Controlled Product<p>{[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]thio}acetic acid is a Research Tool that is used to study the activation of receptors and ion channels. It is a ligand that binds to the receptor in order to activate it. This product has been shown to inhibit the activity of sodium channels as well as calcium channels. <br>{[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]thio}acetic acid has also been shown to block the binding of an antibody to a protein by competitive inhibition. This product can be used for research on Cell Biology and Pharmacology. <br>This compound is not intended for therapeutic use, but rather as a research tool for scientists in the fields of cell biology and pharmacology.</p>Formula:C15H12N2O2S2Purity:Min. 95%Molecular weight:316.4 g/mol4-{[(9H-fluoren-9-yl)methoxy]carbonyl}morpholine-2-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C20H19NO5Purity:Min. 95%Molecular weight:353.4 g/mol(1R,2S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)cyclohexane-1-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C22H23NO4Purity:Min. 95%Molecular weight:365.4 g/mol2-(3-Bromophenyl)-1H-imidazole
CAS:Versatile small molecule scaffoldFormula:C9H7BrN2Purity:Min. 95%Molecular weight:223.07 g/mol
